Chapter 7 226 19. Lundberg SM, Erion G, Chen H, et al. From local explanations to global understanding with explainable AI for trees. Nature Machine Intelligence 2020; 2(1): 56-67. 20. Seabold S, Perktold J. Statsmodels: Econometric and Statistical Modeling with Python. Proceedings of the 9th Python in Science Conference 2010; 2010. 21. Del Valle DM, Kim-Schulze S, Huang HH, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. (1546-170X (Electronic)). 22. Moore JB, June CH. Cytokine release syndrome in severe COVID-19. (1095-9203 (Electronic)). 23. Huang KJ, Su Ij Fau - Theron M, Theron M Fau - Wu Y-C, et al. An interferon-gamma-related cytokine storm in SARS patients. (0146-6615 (Print)). 24. Zeng F, Huang Y, Guo Y, et al. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. (1878-3511 (Electronic)). 25. Mantovani A, Morrone MC, Patrono C, et al. Long Covid: where we stand and challenges ahead. Cell Death & Differentiation 2022; 29(10): 1891-900. 26. Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. (1040-8401 (Print)). 27. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nature Reviews Microbiology 2023; 21(3): 133-46. 28. Stam SA-OX, Vulto A, Vos MJ, et al. Rationale and design of the CORE (COrticosteroids REvised) study: protocol. (2044-6055 (Electronic)). 29. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. (1758-535X (Electronic)). 30. Hewett SJ, Jackman NA, Claycomb RJ. Interleukin-1β in Central Nervous System Injury and Repair. (2279-5855 (Print)). 31. Kihara T, Toriuchi K, Aoki H, Kakita H, Yamada Y, Aoyama M. Interleukin-1β enhances cell adhesion in human endothelial cells via microRNA-1914–5p suppression. Biochemistry and Biophysics Reports 2021; 27: 101046. 32. Gómez-Rial J, Currás-Tuala MJ, Rivero-Calle I, et al. Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology. Frontiers in Immunology 2020; 11. 33. Mendiola AS, Cardona AE. The IL-1β phenomena in neuroinflammatory diseases. (1435-1463 (Electronic)). 34. Stefanou MI, Palaiodimou L, Bakola E, et al. Neurological manifestations of long-COVID syndrome: a narrative review. (2040-6223 (Print)). 35. O’Rourke RA-O, Lumeng CA-O. Pathways to Severe COVID-19 for People with Obesity. (1930739X (Electronic)). 36. Semnani-Azad ZA-O, Blanco Mejia S, Connelly PW, et al. The association of soluble CD163, a novel biomarker of macrophage activation, with type 2 diabetes mellitus and its underlying physiological disorders: A systematic review. (1467-789X (Electronic)).
RkJQdWJsaXNoZXIy MTk4NDMw